Gastrointestinal stromal tumor

>

CURE’s gastrointestinal stromal tumor page features the latest cancer news and updates on gastrointestinal stromal tumors Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in the gastrointestinal stromal tumor.

Latest News

YouTube is a popular video service developed by Google | Image credit: © Proxima Studio - © stock.adobe.com
Grace Helbig, Joaquin Castro Announces Cancer Diagnoses and More

July 7th 2023

From YouTuber Grace Helbig announcing her cancer diagnosis to the NFL’s Foster Moreau being in full remission, here’s what’s happening in the oncology space this week.

GIST survivor, Lee Keenan, standing with his racing bike. | Photo by Arielle Gallione
Lining Up New Options for GIST

June 14th 2023

Qinlock Becomes Preferred Second-Line Drug for GIST Subset
Qinlock Becomes Preferred Second-Line Drug for GIST Subset

March 21st 2023

outline of two faces on a black background © tomozina1-stock.adobe.com.
Cancer Helped Me Acknowledge and Appreciate My Dual Identity
By DW

March 7th 2023

GIST survivors experience cancer-related cognitive impairment
Many Survivors of GISTs, a Rare Cancer, May Experience Cancer-Related Cognitive Impairments After Treatment

October 5th 2022

More News

Site Logo

Treatment Updates

Susan R. Peck, PhD
February 19th 2009

Treatment updates from the 2009 ASCO Gastrointestinal Cancers Symposium.

Site Logo

Kidney, Head and Neck Cancers & MDS

Elizabeth Whittington
March 24th 2006

Revlimid is approved for certain types of myelodysplastic syndrome, and Sutent was approved for both advanced kidney cancer and gastrointestinal stromal tumor.

<12